Fay Cafferty

3.5k total citations · 1 hit paper
56 papers, 2.0k citations indexed

About

Fay Cafferty is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Fay Cafferty has authored 56 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 19 papers in Surgery and 17 papers in Oncology. Recurrent topics in Fay Cafferty's work include Testicular diseases and treatments (8 papers), Prostate Cancer Treatment and Research (7 papers) and Colorectal Cancer Screening and Detection (6 papers). Fay Cafferty is often cited by papers focused on Testicular diseases and treatments (8 papers), Prostate Cancer Treatment and Research (7 papers) and Colorectal Cancer Screening and Detection (6 papers). Fay Cafferty collaborates with scholars based in United Kingdom, Netherlands and Canada. Fay Cafferty's co-authors include Ruth E. Langley, C. Coyle, Claire L. Vale, Mahesh Parmar, Linda Sharples, Stephen W. Duffy, Dennis Wat, I M Bowler, Rachel Evans and Colin Gelder and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Neurology.

In The Last Decade

Fay Cafferty

54 papers receiving 1.9k citations

Hit Papers

Metformin as an adjuvant treatment for cancer: a systemat... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
    2016 337 citations C. Coyle, Fay Cafferty et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fay Cafferty United Kingdom 22 578 523 410 401 354 56 2.0k
Bee‐Choo Tai Singapore 24 776 1.3× 540 1.0× 736 1.8× 377 0.9× 211 0.6× 65 2.8k
Tineke J. Smilde Netherlands 25 524 0.9× 631 1.2× 629 1.5× 319 0.8× 419 1.2× 71 2.3k
Ian Chin‐Yee Canada 27 368 0.6× 559 1.1× 344 0.8× 615 1.5× 188 0.5× 127 4.0k
Christos Damaskos Greece 25 404 0.7× 584 1.1× 511 1.2× 832 2.1× 281 0.8× 175 2.2k
Manish I. Patel Australia 31 1.7k 2.9× 510 1.0× 846 2.1× 602 1.5× 297 0.8× 151 3.2k
Xabier García‐Albéniz United States 28 546 0.9× 1.1k 2.2× 579 1.4× 464 1.2× 453 1.3× 88 2.5k
Christian Garbar France 24 216 0.4× 419 0.8× 291 0.7× 448 1.1× 168 0.5× 75 1.9k
Thomas E. Delea United States 26 529 0.9× 763 1.5× 304 0.7× 298 0.7× 181 0.5× 136 2.4k
Lisa Bomgaars United States 26 348 0.6× 387 0.7× 526 1.3× 419 1.0× 96 0.3× 57 2.3k
Olufemi J. Ogunbiyi Nigeria 19 311 0.5× 456 0.9× 241 0.6× 227 0.6× 134 0.4× 70 1.8k

Countries citing papers authored by Fay Cafferty

Since Specialization
Citations

This map shows the geographic impact of Fay Cafferty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fay Cafferty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fay Cafferty more than expected).

Fields of papers citing papers by Fay Cafferty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fay Cafferty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fay Cafferty. The network helps show where Fay Cafferty may publish in the future.

Co-authorship network of co-authors of Fay Cafferty

This figure shows the co-authorship network connecting the top 25 collaborators of Fay Cafferty. A scholar is included among the top collaborators of Fay Cafferty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fay Cafferty. Fay Cafferty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Birtle, Alison, Robert J. Jones, John Chester, et al.. (2024). Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial. Journal of Clinical Oncology. 42(13). 1466–1471. 25 indexed citations
3.
Rescigno, Pasquale, Maria D. Fenor de la Maza, Stephanie Burnett, et al.. (2024). Phase II trial of pembrolizumab for patients suffering from metastatic castration resistant prostate cancer (mCRPC) with DNA repair defects, high tumour mutation burden, and/or high CD3 counts (PERSEUS1).. Journal of Clinical Oncology. 42(4_suppl). 138–138. 1 indexed citations
4.
Li, Vivien, Baptiste Leurent, Frederik Barkhof, et al.. (2022). Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis. Neurology. 98(18). 754–764. 12 indexed citations
5.
Macnair, Archie, Sharon Love, Macey L. Murray, et al.. (2021). Accessing routinely collected health data to improve clinical trials: recent experience of access. Trials. 22(1). 340–340. 18 indexed citations
6.
Beyer, J., Laurence Collette, Gedske Daugaard, et al.. (2020). Prognostic factors in advanced seminoma: An analysis from the IGCCCG Update Consortium.. Journal of Clinical Oncology. 38(6_suppl). 386–386. 9 indexed citations
7.
Allum, William, Elizabeth Smyth, Jane Blazeby, et al.. (2019). Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro-oesophageal junction. British journal of surgery. 106(9). 1204–1215. 4 indexed citations
8.
9.
Langley, Ruth E., Richard H. Wilson, Fay Cafferty, et al.. (2019). Aspirin as adjuvant treatment for colorectal cancer: Rationale and progress of the Add-Aspirin trial.. Journal of Clinical Oncology. 37(15_suppl). TPS3624–TPS3624. 1 indexed citations
10.
Cafferty, Fay, et al.. (2017). Co-enrolment of Participants into Multiple Cancer Trials: Benefits and Challenges. Clinical Oncology. 29(7). e126–e133. 7 indexed citations
11.
Coyle, C., Fay Cafferty, & Ruth E. Langley. (2016). Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?. Current Colorectal Cancer Reports. 12(1). 27–34. 44 indexed citations
12.
Wat, Dennis, Colin Gelder, Sam Hibbitts, et al.. (2008). The role of respiratory viruses in cystic fibrosis. Journal of Cystic Fibrosis. 7(4). 320–328. 172 indexed citations
13.
Duffy, Stephen W., Irıs D. Nagtegaal, Matthew Wallis, et al.. (2008). Correcting for Lead Time and Length Bias in Estimating the Effect of Screen Detection on Cancer Survival. American Journal of Epidemiology. 168(1). 98–104. 182 indexed citations
14.
Cafferty, Fay, Peter Sasieni, & Stephen W. Duffy. (2008). A deterministic model for estimating the reduction in colorectal cancer incidence due to endoscopic surveillance. Statistical Methods in Medical Research. 18(2). 163–182. 7 indexed citations
15.
Lawrence, Gill, Matthew Wallis, P C Allgood, et al.. (2008). Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias. Breast Cancer Research and Treatment. 116(1). 179–185. 36 indexed citations
16.
Vuylsteke, Alain, et al.. (2006). The impact of administration of tranexamic acid in reducing the use of red blood cells and other blood products in cardiac surgery. BMC Anesthesiology. 6(1). 9–9. 11 indexed citations
17.
Baskett, Roger J.F., Fay Cafferty, Sarah Powell, et al.. (2006). Total Arterial Revascularization is Safe: Multicenter Ten-Year Analysis of 71,470 Coronary Procedures. The Annals of Thoracic Surgery. 81(4). 1243–1248. 22 indexed citations
18.
Sharples, Linda, et al.. (2006). Evaluation of the ventricular assist device programme in the UK. Health Technology Assessment. 10(48). 1–119, iii. 45 indexed citations
19.
Nathan, James A., et al.. (2006). A Randomized Controlled Trial of Follow-up of Patients Discharged From the Hospital Following Acute Asthma. CHEST Journal. 130(1). 51–57. 17 indexed citations
20.
Stoica, Șerban, Fay Cafferty, Craig J. Taylor, et al.. (2006). The Cumulative Effect of Acute Rejection on Development of Cardiac Allograft Vasculopathy. The Journal of Heart and Lung Transplantation. 25(4). 420–425. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bee‐Choo Tai Breakdown of academic impact, for papers by Tineke J. Smilde Breakdown of academic impact, for papers by Ian Chin‐Yee Breakdown of academic impact, for papers by Christos Damaskos Breakdown of academic impact, for papers by Manish I. Patel Breakdown of academic impact, for papers by Xabier García‐Albéniz Breakdown of academic impact, for papers by Christian Garbar Breakdown of academic impact, for papers by Thomas E. Delea Breakdown of academic impact, for papers by Lisa Bomgaars Breakdown of academic impact, for papers by Olufemi J. Ogunbiyi
Rankless by CCL
2026